|
Gli articoli
Management
Politica sanitaria
Medicina e New
Economy
I Libri che vi consigliamo:
Analisi economiche
Piccola enciclopedia su
qualita', management, accreditamento
Ossevatorio
farmaci (cergas 2002)
|
|
 La spesa
sanitaria e altri indicatori di salute nei dati Ocse 2003 di Laura
Fioravanti e Federico Spandonaro da Monitor Rivista della Agenzia per i servizi
sanitari nazionali
i nosti link preferiti: economia sanitaria
Economia & Management,
diretta da Claudio Dematté
Il Centro per la Valutazione della Efficacia della Assistenza Sanitaria Ce.V.E.A.S.
e i link collegati
Cergas
osservatorio farmaci
Farmacoeconomia
Economia
Sanitaria e i dati
economici in Sanità
Database
Health for all (23.12.2003) dall'ISTAT
e parte
sanitaria
WHO
Global Programme on Evidence for Health Policy
Health
evidence network
http://www.edscuola.it/archivio/handicap/spesa_farmaceutica.pdf
http://www.farmindustria.it/farmindustria/html/prometeo.asp?menu2expand=elTwo
http://www.farmindustria.it/farmindustria/html/index.asp
Fondo
sanitario a quota 81 miliardi e i commenti
con ripartizioni
http://www.careonline.it/
Analisi
economiche in collaborazione da GIMBE
Introduction
to health economics for physicians Meltze
Lancet Volume 358, Number 9286
FREE (basta regsitrarsi)
CARATTERISTICHE E
CONFIGURAZIONE DEI COSTI NEL SETTORE SANITARIO: UN MODELLO LOGICO DI ANALISI A
SUPPORTO DELLE DECISIONI
Dr. Franco Ancona, economista PricewaterhouseCoopers
Italia
O'Brien
BJ, Heyland D, Richardson WS, et al. How to use an article on economic analysis
of clinical practice. JAMA 1997;277:1552-1557 and 1802-1806
Quality
of economic evaluations in health care
Il caro
vecchio BMJ: (libero)
- Raftery
J. Economic evaluation: an introduction.BMJ 1998;316:1013-4
- Byford
S, Raftery J. Perspectives in economic evaluation. BMJ
1998;316:1529-1530
- Palmer
S, Torgerson DJ. Definitions of efficiency. BMJ 1999;318:1136
- Palmer
S, Byford S, Raftery J. Types of economic evaluation. BMJ 1999;318:1349
- Torgerson
D, Raftery J. Measuring outcomes in economic evaluations. BMJ
1999;318:1413
- Palmer
S, Raftery J. Opportunity cost. BMJ 1999;318:1551-2
- Briggs
A. Handling uncertainty in economic evaluation. BMJ 1999;319:120
- Torgerson
DJ, Raftery J. Discounting. BMJ 1999;319:914-915
- Briggs
A, Gray A. Using cost effectiveness information. BMJ 2000;320:246-246
- Torgerson
DJ, Campbell MK. Cost effectiveness calculations and sample size. BMJ
2000;321:697
- Torgerson
DJ, Campbell MK. Use of unequal randomisation to aid the economic
efficiency of clinical trials. BMJ 2000;321:759
- Torgerson
TJ, Byford S. Economic modelling before clinical trials. BMJ 2002;325:98
- Gosden
TB, Torgeson DJ. Converting international cost effectiveness data to UK
prices. BMJ 2002;325 275-276
SANITARIA.
- La
valutazione economica in pratica: crescita della letteratura ed esperienze
applicative
EDITORIAL
REVIEW:
Andrew J.
Palmer
Health economics—what the nephrologist should know
Nephrol. Dial. Transplant., Jun 2005; 20: 1038 - 1041.
 |
|
ORIGINAL
ARTICLES:
Andrew
J. Palmer,
Daniel M. D. Tucker, William J. Valentine, Stéphane Roze, Sylvie
Gabriel, and Daniel J. Cordonnier
Cost-effectiveness of irbesartan in diabetic nephropathy: a
systematic review of published studies
Nephrol. Dial. Transplant., Jun 2005; 20: 1103 - 1109. |
|
Interpreting
cost-effectiveness in dialysis: can the most expensive be more expensive?P
A McFarlane Kidney Int 69: 2120-2121; doi:10.1038/sj.ki.5001556
Abstract
Economic
implications of screening strategies in arteriovenous fistulae
M
Tonelli, S Klarenbach, K Jindal and B Manns for the
Alberta
Kidney Disease Network Kidney
Int 69: 2219-2226; advance online publication, May 3, 2006; doi:10.1038/sj.ki.5000151
Abstract
non e' proprio economia ma ci aiuta a ragionare
e a scegliere meglio dallAm J Kidney Dis
Volume
48, Issue
1, Pages 159-166 (July 2006)Surrogate
Markers in Clinical Studies: Problems Solved or Created?
|
